Staffan Encrantz, Director at Sight Sciences, Inc. (SGHT), bought 1,047,800 shares at $22.92 ($21.9M) on 2021-12-01, disclosed to the SEC on 2021-12-01.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.84 | 84,254 | $1.6M | 7.2% |
| 2 | $18.84 | 84,254 | $1.6M | 7.2% |
| 3 | $19.06 | 2,200 | $42K | 0.2% |
| 4 | $19.44 | 72,135 | $1.4M | 6.4% |
| 5 | $19.44 | 72,135 | $1.4M | 6.4% |
| 6 | $20.40 | 94,969 |
| $1.9M |
| 8.8% |
| 7 | $20.40 | 94,969 | $1.9M | 8.8% |
| 8 | $20.96 | 56,836 | $1.2M | 5.4% |
| 9 | $20.96 | 56,836 | $1.2M | 5.4% |
| 10 | $21.43 | 27,716 | $594K | 2.7% |
| 11 | $21.43 | 27,716 | $594K | 2.7% |
| 12 | $22.36 | 123,931 | $2.8M | 12.7% |
| 13 | $22.36 | 123,931 | $2.8M | 12.7% |
| 14 | $22.92 | 62,959 | $1.4M | 6.6% |
| 15 | $22.92 | 62,959 | $1.4M | 6.6% |
| Total | $20.90 avg | 1,047,800 | $21.9M | 100% |
| Filing → |
| SGHT | BUY | 2025-06-06 | $646K | — | Filing → |
| SGHT | BUY | 2025-06-03 | $753K | — | Filing → |
| SGHT | BUY | 2025-05-29 | $904K | — | Filing → |